NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability.
Meredith L.L. Leong, Weiqun Liu, Nicole C. Fay…·Ole Audun Werner Haabeth
This paper introduces NTX250, an mRNA-based immunotherapy platform for HPV-associated cancers that induces tumor regression and durable immune memory in preclinical models.